Moderna Recursion: Which Cutting-Edge Path Is Best in 2026
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Young professionals can benefit from targeted wealth growth tips. Learn how to maximize your earnings and investments.
22,851 articlesTwo biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
SoFi faces a fragile mix of improving profitability and credit risk as growth opportunities widen. This analysis weig...
PepsiCo drives growth with international momentum while Procter & Gamble shines in beauty; both set the stage for a d...
Rocket Lab’s stock has faced renewed pressure as the market weighs contracting demand signals and execution risks. Th...
A trio of blue-chip dividend payers is delivering double-digit gains and reliable income for retirees as 2026 unfolds...
A major investment manager recently disclosed a sizable position in Varonis Systems. This article unpacks what the mo...
Nvidia delivered a blockbuster quarter, but the stock cooled off the next day. This article unpacks the mystery behin...
When the broader market fell, one name stood out. This article explains why plug power stock defied the downturn, fea...
Three consumer-facing stocks — Planet Fitness, Brown-Forman, and Campbell’s — moved on earnings, tariffs, and margin ...
When a big fund trims a REIT stake, investors watch for clues about rental income and stock performance. This article...
The Fed’s decision to hold rates steady sent ripples through the market as inflation worries resurfaced. Here’s what ...
Bank of America reinstates Buy on Microsoft, guiding toward a $500 price target as Azure growth and Copilot adoption ...